Unraveling intestinal microbiota's dominance in polycystic ovary syndrome pathogenesis over vaginal microbiota

Front Cell Infect Microbiol. 2024 Mar 28:14:1364097. doi: 10.3389/fcimb.2024.1364097. eCollection 2024.

Abstract

Background: Polycystic ovary syndrome (PCOS) is a prevalent endocrine disease in women, intricately linked to hormonal imbalances. The microbiota composition plays a pivotal role in influencing hormonal levels within the body. In this study, we utilized a murine model to investigate how intestinal and vaginal microbiota interact with hormones in the development of PCOS.

Methods: Twenty female mice were randomly assigned to the normal group (N) and the model group (P), where the latter received daily subcutaneous injections of 0.1 mL DHEA (6 mg/100 g). Throughout the experiment, we evaluated the PCOS mouse model by estrus cycle, serum total testosterone (T), prolactin (PRL) and luteinizing hormone (LH) levels, and ovarian pathological morphology. The microbial composition in both intestinal content and vaginal microbiota were studied by 16S rRNA gene high-throughput sequencing.

Results: Compared with the N group, the P group showed significant increases in body weight, T, and PRL, with significant decrease in LH. Ovaries exhibited polycystic changes, and the estrous cycle was disrupted. The intestinal microbiota result shows that Chao1, ACE, Shannon and Simpson indexes were decreased, Desulfobacterota and Acidobacteriota were increased, and Muribaculaceae, Limosilactobacillus and Lactobacillus were decreased in the P group. T was significantly positively correlated with Enterorhabdus, and LH was significantly positively correlated with Lactobacillus. The analysis of vaginal microbiota revealed no significant changes in Chao1, ACE, Shannon, and Simpson indices. However, there were increased in Firmicutes, Bacteroidota, Actinobacteriota, Streptococcus, and Muribaculaceae. Particularly, Rodentibacter displayed a robust negative correlation with other components of the vaginal microbiota.

Conclusion: Therefore, the response of the intestinal microbiota to PCOS is more significant than that of the vaginal microbiota. The intestinal microbiota is likely involved in the development of PCOS through its participation in hormonal regulation.

Keywords: dehydroepiandrosterone; intestinal microbiota; polycystic ovary syndrome; sex hormone; vaginal microbiota.

MeSH terms

  • Animals
  • Female
  • Gastrointestinal Microbiome*
  • Humans
  • Luteinizing Hormone
  • Mice
  • Microbiota*
  • Polycystic Ovary Syndrome*
  • RNA, Ribosomal, 16S / genetics
  • Testosterone

Substances

  • Luteinizing Hormone
  • RNA, Ribosomal, 16S
  • Testosterone

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was financially supported by Characterization of intestinal microbiota in mice with polycystic ovary syndrome (20232910).